Should cannabis still be a Schedule I drug?

The Drug Enforcement Agency received a recommendation to reclassify cannabis as a Schedule III drug, a move that would be a boon to research ...

US DEA will reclassify marijuana, ease restrictions, AP sources say

It comes after President Joe Biden called for a review of federal marijuana law in October 2022 and moved to pardon thousands of Americans ...

The Federal Government's Drug Scheduling System Remains ...

Drug Law expert Robert Mikos advocates for a new approach as marijuana is poised to be rescheduled by DEA.

The U.S. Is Easing Marijuana Restrictions. Here's How It Works.

A new federal rule would reclassify marijuana as a less-dangerous, Schedule III drug. It's a significant shift, even as it does not legalize ...

Removal of cannabis from Schedule I of the Controlled Substances Act

The majority of 2024 public comments supported descheduling, decriminalizing, or legalizing marijuana at the federal level.

Marijuana could soon be downgraded from a Schedule 1 drug - NPR

The federal government may soon change how marijuana is regulated. The Drug Enforcement Administration has kicked off a review of whether ...

Biden rescheduling marijuana: Schedule 1 vs Schedule 3, explained

President Biden endorsed the Justice Department's move to reclassify marijuana from a Schedule I drug to a Schedule III drug Thursday.

Drug Fact Sheet: Marijuana/Cannabis - DEA.gov

THC (delta-. 9-tetrahydrocannabinol) is believed to be the main ingredient that produces the psychoactive effect. WHAT IS ITS ORIGIN? Marijuana is grown in the ...

From Schedule I to Schedule III: Potential Shift in Marijuana's Legal ...

Marijuana and delta-9 THC are currently listed in Schedule I of the CSA. The CSA places drugs in one of five Schedules, with Schedule I being ...

What reclassifying marijuana means for Americans | PBS News

If marijuana gets reclassified, would it legalize recreational cannabis nationwide? No. Schedule III drugs — which include ketamine, anabolic ...

Marijuana may soon be a Schedule III drug: What will change?

The new rule under consideration would move it down two levels to Schedule III, below Schedule II drugs like cocaine, methamphetamine, fentanyl, oxycodone and ...

Marijuana Classification and Implications of Rescheduling - KLRD

On May 21, 2024, the U.S. Department of Justice Drug Enforcement Administration published a notice of proposed rulemaking to transfer ...

Schedules of Controlled Substances: Rescheduling of Marijuana

The Department of Justice ("DOJ") proposes to transfer marijuana from schedule I of the Controlled Substances Act ("CSA") to schedule III of ...

Legal Consequences of Rescheduling Marijuana - CRS Reports

Marijuana is a Schedule I controlled substance under the CSA. Federal law defines hemp as the cannabis plant or any part of that plant with a ...

Drug Scheduling - DEA.gov

A Listing of drugs and their schedule are located at Controlled Substance Act (CSA) Scheduling or CSA Scheduling by Alphabetical Order. These lists describes ...

HHS Shakes Things Up on Marijuana Scheduling and DEA Abides

The US Drug Enforcement Administration (DEA) issued a Notice of Proposed Rulemaking (NPRM) to initiate the rescheduling of marijuana from a Schedule I to a ...

Justice Department Submits Proposed Regulation to Reschedule ...

Proposed rule seeks to move marijuana from schedule I to schedule III, emphasizing its currently accepted medical use in treatment in the United States.

The Science behind the DEA's Long War on Marijuana

Experts say listing cannabis among the world's deadliest drugs ignores decades of scientific and medical data. But attempts to delist it ...

Justice Dept plans to reschedule marijuana as a lower-risk drug - CNN

The Biden administration moved Tuesday to reclassify marijuana as a lower-risk substance, a person familiar with the plans told CNN, ...

U.S. Drug Enforcement Administration Proposes Reclassification of ...

Drug Enforcement Administration (DEA) issued a proposed rule to move marijuana from its current classification as a Schedule I drug to a ...